Replimune

Replimune is developing novel, proprietary oncolytic immunotherapies intended to improve both the direct anti-tumor effects of selective virus replication and the potency of the immune response to the tumor antigens released.
Type
Private
HQ
Milton, GB
Founded
2015
Replimune was founded in 2015 and is headquartered in Milton, GB

Replimune Office Locations

Replimune has offices in Milton, Woburn
Milton, GB (HQ)
69 Park Dr
Woburn, US
18 Commerce Way

Replimune Metrics

Summary Metrics

Founding Date

2015

Total Funding

$30 m

Latest funding size

$30 m

Time since last funding

over 1 year

Investors

Replimune's latest funding round in September 2015 was reported to be $30 m. In total, Replimune has raised $30 m

Replimune Company Life

You may also be interested in